Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens - Trial NCT06050278
Access comprehensive clinical trial information for NCT06050278 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Milano Bicocca and is currently Recruiting. The study focuses on NSCLC. Target enrollment is 10 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Milano Bicocca
Timeline & Enrollment
N/A
Apr 03, 2023
Apr 01, 2026
Primary Outcome
Tapestri success rate
Summary
The goal of this observational study is to evaluate the feasibility of a single cell mutation
 research method in a panel of known oncogenes, using the Tapestri method. Tissue samples will
 be obtained after surgical treatment in patients with I-II-III stage NSCLC.
Data Source
ClinicalTrials.gov
NCT06050278
Non-Device Trial